A detailed history of Virtu Financial LLC transactions in Immunic, Inc. stock. As of the latest transaction made, Virtu Financial LLC holds 30,359 shares of IMUX stock, worth $42,502. This represents 0.0% of its overall portfolio holdings.

Number of Shares
30,359
Holding current value
$42,502
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$1.08 - $1.95 $32,787 - $59,200
30,359 New
30,359 $50,000
Q1 2024

May 20, 2024

BUY
$1.14 - $1.53 $21,760 - $29,204
19,088 New
19,088 $25,000
Q2 2023

Jul 27, 2023

BUY
$1.33 - $2.51 $89,673 - $169,234
67,424 New
67,424 $169,000

Others Institutions Holding IMUX

About IMMUNIC, INC.


  • Ticker IMUX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,565,000
  • Market Cap $42.8M
  • Description
  • Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...
More about IMUX
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.